Patient, carer and health service outcomes of nurse-led early discharge after breast cancer surgery: a randomised controlled trial

British Journal of Cancer
M WellsA Thompson

Abstract

Patients with breast cancer who require axillary clearance traditionally remain in hospital until their wound drains are removed. Early discharge has been shown to improve clinical outcomes, but there has been little assessment of the psychosocial and financial impact of early discharge on patients, carers and the health service. This study aimed to evaluate the effectiveness of a nurse-led model of early discharge from hospital. Main outcome measures were quality of life and carer burden. Secondary outcomes included patient satisfaction, arm morbidity, impact on community nurses, health service costs, surgical cancellations and in-patient nursing dependency. A total of 108 patients undergoing axillary clearance with mastectomy or wide local excision for breast cancer were randomised to nurse-led early discharge or conventional stay. Nurse-led early discharge had no adverse effects on quality of life or patient satisfaction, had little effect on carer burden, improved communication between primary and secondary care, reduced cancellations and was safely implemented in a mixed rural/urban setting. In total, 40% of eligible patients agreed to take part. Nonparticipants were significantly older, more likely to live alone and had l...Continue Reading

References

Aug 17, 1991·BMJ : British Medical Journal·A H LeylandF A Boddy
May 1, 1983·Journal of Gerontology·B C Robinson
Mar 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M J BradyG Shiomoto
Oct 22, 1998·The British Journal of Surgery·S A McIntosh, A D Purushotham
Nov 7, 1998·BMJ : British Medical Journal·N BundredA Baildam
Mar 10, 1999·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J BonnemaT Wiggers
Sep 15, 2000·BMJ : British Medical Journal·M CampbellP Tyrer
Apr 20, 2001·JAMA : the Journal of the American Medical Association·D MoherUNKNOWN CONSORT Group (Consolidated Standards of Reporting Trials)
Sep 26, 2002·European Journal of Cancer Care·C Thomas, S M Morris
Jan 21, 2004·The Breast : Official Journal of the European Society of Mastology·K HorganA Robertson

❮ Previous
Next ❯

Citations

Jul 13, 2012·The Cochrane Database of Systematic Reviews·Michèle AubinPierre-Hugues Carmichael
Jan 30, 2009·Health & Social Care in the Community·Rachel BorthwickLucy Stuttard
Jun 8, 2013·The British Journal of Psychiatry : the Journal of Mental Science·Nisha DograPanos Vostanis
Jan 17, 2009·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·Marielle OuwensRichard Grol
Feb 28, 2016·Annals of Surgical Oncology·Erin CordeiroTulin Cil
Nov 7, 2019·The Cochrane Database of Systematic Reviews·Dina Bosnjak KuharicLivia Puljak
Jul 11, 2019·BMC Health Services Research·Hélène RossinotMatthieu de Stampa
Nov 6, 2012·The Medical Journal of Australia·Gideon A CaplanLouise Barclay
Mar 27, 2009·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Gillian R HuntPeter Salmon
Nov 20, 2010·Journal of Evaluation in Clinical Practice·Lisa GrahamChristopher D Sutton
Jan 11, 2011·Journal of the National Cancer Institute·Julie LemieuxValérie Théberge
Jun 6, 2020·BMJ Supportive & Palliative Care·Raymond Javan ChanPatsy Yates

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Software Mentioned

EUROQOL

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.